Group cash flow statement FOR THE YEAR ENDED 31 DECEMBER 2003 49 2003 2002 2001 Notes m m m Net cash inflow outflow from operating activities 26 119.1 6.2 8.0 Returns on investment and servicing of finance Interest received 2.0 0.7 1.2 Interest paid 0.1 0.1 0.2 Interest element of finance lease payments 0.8 Net cash inflow from returns on investments and servicing of finance 1.1 0.6 1.0 Taxation 5.8 0.1 Capital expenditure and financial investment B Purchase of tangible fixed assets 6.0 11.5 8.4 Funds advanced to joint venture 0.5 Net cash outflow from capital expenditure and financial investment 6.0 11.5 8.9 Acquisitions and disposals C Purchase of Berna Products Corporation net of cash acquired 15 3.9 Net cash outflow from acquisitions and disposals 3.9 Net cash inflow outflow before management of liquid resources and financing 104.5 17.0 15.9 Management of liquid resources 27 61.9 19.8 Financing Net proceeds from issue of new shares D Baxter subscription 7.0 7.0 3.5 Other 1.9 0.8 0.8 Proceeds from new finance lease commitment 12.7 Net cash inflow from financing 8.9 7.8 17.0 Increase decrease in cash for the financial year 27 51.5 9.2 20.9 The accompanying notes are an integral part of this Group cash flow statement.
C ACQUISITION OF BERNA PRODUCTS CORPORATION D BAXTER SUBSCRIPTION ON 27 AUGUST 2003, ACAMBIS ACQUIRED 100% OF THE 12 PEOPLE BASED IN MIAMI, FLORIDA AND TORONTO, IN DECEMBER 2000, BAXTER AGREED TO SUBSCRIBE FOR 28M SHARE CAPITAL OF BERNA PRODUCTS CORPORATION BPC FOR CANADA.
CURRENTLY BPC HAS ONE SOURCE OF TURNOVER: WORTH OF NEW ACAMBIS SHARES.
THIS SUBSCRIPTION WAS UP TO A TOTAL OF C. 7.4M $12.5M.
3.9M $6.4M WAS PAID SALES OF VIVOTIF, AN ORAL TYPHOID VACCINE.
FURTHER MADE IN FOUR INSTALMENTS BETWEEN DECEMBER 2000 AND IN 2003, WITH THE BALANCE DUE IN CASH AND MILESTONE INFORMATION ON THE TERMS OF THE ACQUISITION IS MARCH 2003 AT AN AVERAGE PRICE OF 1.30 PER ORDINARY PAYMENTS OVER THE NEXT COUPLE OF YEARS.
BPC IS A SALES, SHOWN IN NOTE 15 ON PAGE 59.
FOLLOWING ITS FINAL SUBSCRIPTION, BAXTERS PROMOTION AND DISTRIBUTION ORGANISATION, EMPLOYING SHAREHOLDING IN ACAMBIS WAS 20.3%.
ON 18 DECEMBER 2003, BAXTER SOLD ITS TOTAL HOLDING IN ACAMBIS.
